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ASSOCIATION BETWEEN PREOPERATIVE FIBRINOGEN LEVELS AND
OUTCOME FOLLOWING ENDOVASCULAR REPAIR OF RUPTURED
ABDOMINAL AORTIC ANEURYSMS
Aim: To investigate the potential association between preoperative levels of fibrinogen and
outcome following endovascular aortic repair (EVAR) of ruptured abdominal aortic
aneurysms (RAAAs).
Methods: Consecutive patients undergoing EVAR for RAAA between March 2010 and May
2016 were recruited from a single vascular center. Patient details including fibrinogen levels
on admission were extracted from case files and 30-day mortality was recorded.  The
association between fibrinogen and outcome, which included 30-day mortality, re-
intervention, endoleaks, major adverse cardiovascular events (MACE) and survival at follow
up, was tested using the independent samples t-test.
Results: Twenty-one patients (20 males, median 71 years) with a RAAA receiving EVAR
and available preoperative fibrinogen levels were included in this study. There were 16
patients with a de novo RAAA and 5 with rupture after a previous EVAR. Of these, 3
patients died within 30 days (14.3%), one intra-operatively and two within 24 hours due to
multiple organ failure. Fibrinogen levels on admission were significantly higher in the group
of survivors when compared to those who died (mean ± standard deviation 456.36±183.72
mg/dl versus 192.57±52.26 mg/dl; p=0.026). None of the remaining examined variables had
statistically significant association with the preoperative fibrinogen levels.
Conclusion: This study suggests a possible relationship between fibrinogen levels on
admission and early mortality in patients undergoing EVAR for a RAAA. Higher fibrinogen
levels, which may indicate a preoperative hypercoagulable profile, seemed to be associated
with better chances of early survival in our small series. Further and larger studies are needed
to clarify this issue and possible future therapeutic implications.
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RAAA is a lethal condition for which immediate surgical intervention is required
[1][2][3][4][5]. Only half the patients reach the hospital alive and of those receiving an
operation only 50% survive, for an overall population mortality of 80-90% [6][7]. For more
than 50 years RAAAs have been treated with the traditional open surgical repair; a major
surgical procedure that requires general anesthesia, midline laparotomy and cross-clamping
of the aorta and iliac arteries.
In the early 1990s, Volodos in Ukraine and Parodi, Palmaz and Barone in Argentina [8][9]
introduced a less invasive endovascular method for elective AAA repair. Over time, these
pioneering devices were improved and commercial development of the technology has meant
that the technique has spread worldwide.
Encouraged by the excellent results of elective EVAR, emergent EVAR has been also used
for RAAAs [10]. Several observational studies suggested that EVAR is superior to open
surgery for RAAAs. Additionally, three recent randomized controlled trials suggested that,
although there were no statistically significant differences in 30-day mortality rates, there was
a consistent but non-significant trend for lower mortality with EVAR at 1 year [11].
If the results of EVAR for RAAA are to be improved, identification of factors influencing
survival is of paramount importance. One of these factors is the clotting profile of RAAA
patients. Coagulation parameters are often found to be deranged in patients presenting with a
RAAA and having a large retroperitoneal hematoma or a free intra-peritoneal rupture.
Building upon this literature, we hypothesized that serum fibrinogen on presentation is a
potential biomarker of early or late outcome in RAAA patients undergoing EVAR [12]. Being
an important component of the coagulation cascade, as well as a major determinant of blood
viscosity, may, in part, explain its association with various vascular disorders and their
prognosis [13]. An increase in plasma fibrinogen levels may reflect or promote a
prothrombotic or hypercoagulable state which may prove to be partly protective in a RAAA
case through hemorrhage cessation. The aim of this retrospective study was to examine the
association between preoperative serum fibrinogen and outcome in patients undergoing
EVAR for RAAA.
METHODS
A consecutive series of 21 patients undergoing EVAR for RAAA between March 2010 and
May 2016 were enrolled in this retrospective study. Patient details were extracted from case
files and only cases with available fibrinogen level on admission were included. The study
was held in a single vascular center based at a university hospital which provides on-call
vascular services for northern Greece every fourth day. The elective EVAR program started
back in 1995, whereas the EVAR service for RAAAs was established in early 1998.
On suspicion of a RAAA, the patient was immediately brought to the computerized
tomography (CT) scanner, with the whole process lasting no more than 15 to 20 minutes. As
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a result, the admission to the scanning room and, subsequently, to the operating room in such
patients usually required a total time of about 30 minutes. In case of a patient being
transferred from a peripheral hospital with the diagnosis of a rupture already made on CT, the
time from admission to the start of the endovascular procedure was even less, because the
patient was taken directly into the operating room, bypassing the emergency room and the
radiology department. In the latter patients, the delay from the onset of symptoms to
aneurysm exclusion depended on several factors beyond our control, such as how quickly the
patient sought medical advice, how quickly the diagnosis of a RAAA was made by the
referring physician, and the distance the patient had to travel by ambulance from the
peripheral hospital to our center.
Patient evaluation was done by means of contrast-enhanced spiral CT of the abdomen and
pelvis [14]. There were no specific hemodynamic inclusion criteria for EVAR. In the
presence of severe hemodynamic instability an aortic occlusion balloon was used. The
vascular surgeon, along with the on-call radiologist, reviewed the CT images, confirmed the
diagnosis of rupture, and assessed aneurysm morphology. All decisions about the type of
treatment offered, including decisions on the type, configuration and size of the endograft,
were made by the on-call vascular specialist.
The anatomic criteria for EVAR in RAAA patients were broadly similar to those used in the
elective setting, the most important morphologic factor being the infrarenal neck. The general
guidelines for suitability were an infrarenal neck length of 10 mm or more, a neck diameter
of 32 mm or less, neck angulation of 60° or less, and a common iliac diameter of 22 mm or
less; also, there could be no bilateral common iliac aneurysms or long iliac occlusions. With
growing experience, however, our selection criteria for both elective and RAAAs had
expanded to the extent that more and more technically challenging cases had been treated by
endovascular means. Consequently, cases with difficult iliac anatomy, such as bilateral severe
iliac occlusive disease, tortuosity, or aneurysmal involvement, had been considered as
potential candidates. In addition, RAAAs with shorter (<10 mm), flared, or severely
angulated proximal necks had also been accepted for EVAR.
Patients who were thought to be suitable for EVAR were immediately transferred to a
dedicated vascular operating room with endovascular facilities. Endovascular repair was
performed by the on-call team, which consisted of a vascular specialist and two vascular
trainees. The procedure was performed with a mobile C-arm image intensifier with digital
subtraction angiography facility (SIEMENS ARCADIS). Arterial access was obtained via
bilateral surgical cutdowns of the common femoral arteries by using skin crease groin
incisions. The procedure was usually performed under local anesthesia with 1% lidocaine.
All patients were monitored noninvasively by the anesthesiologist. When needed intravenous
sedation was administered in an attempt to minimize patient movement and discomfort.
Intravenous fluid and blood resuscitation were kept to a minimum before aneurysm exclusion
to allow hypotensive hemostasis (systolic blood pressure between 80 and 100 mm Hg).
Endotracheal intubation and general anesthesia was reserved for patients who had lost
consciousness and/or those in whom a patent airway could not be maintained. Then the
procedure of EVAR was performed in the usual standard fashion by cannulation of both
femoral arteries with suitably sized sheaths.
Intraoperative angiography was usually performed with manual injection of contrast via a 7F
introducer sheath (Super Arrow Flex, 45 cm long; Arrow International, Reading, Pa) inserted
from the femoral artery contralateral to the side chosen for deployment of the main body of
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the stent graft. The contrast medium used was iodixanol (Visipaque; Amersham Health) or
iopamidol (Iopamiro 300; Bracco, Italy). Intraoperative angiography determined the level of
the lowest renal artery and, later in the procedure, the origins of the internal iliac arteries. The
main body of the device was introduced over a stiff guidewire, such as the Amplatz Super
Stiff (Boston Scientific, Watertown, Mass) or the Lunderquist guidewire (TSMG-35-260-5-
LES2; William Cook Europe, Denmark) with the help of a 5F guiding catheter, such as the
Headhunter (Boston Scientific, Meditech). The combination of a 5F cobra-shaped selective
angiographic catheter (Boston Scientific, Meditech) and an angled Terumo guidewire (0.035
inches [180 cm]; Terumo Corporation, Tokyo, Japan) was used to catheterize the short limb
of the main body of the bifurcated stent grafts in most cases. In all cases, stent grafts were
additionally dilated with a suitable balloon to ensure adequate sealing. Postdilation was
performed by using a compliant aortic balloon (Reliant; Medtronic, World Medical
Manufacturing Corp, Sunrise, Fla) for proximal and distal landing zone fixation.
The type of stent graft was chosen depending on the surgeon’s preference and expertise, the
anatomic characteristics of the aneurysm, and, most importantly, the device availability [15].
As a result of local hospital policy, there is no inventory of an AAA stent graft available in
our unit. Instead, emergency access to suitable endografts was through the locally based
company representatives. As a result, whatever device was more readily available was used.
Although this policy could potentially lead to inevitable logistic delays, frequent
communication with the company representatives resulted in timely endograft availability. In
cases in which the diagnosis of an RAAA was known or suspected through information from
the referring hospital or the ambulance service, we alerted the company clinical specialists
before patient arrival, and the stent graft was available to us as the patient was being brought
to the operating room.
The primary outcome in this study included 1) 30-day mortality, 2) the survival at follow-up,
3) aortic related re-interventions, 4) endoleaks and 5) major adverse cardiovascular events
(MACE). The latter was defined as all-cause mortality, major lower limb amputation,
ischemic cardiac events, stroke and all-aortic stent-graft related events.
All statistical analyses were carried out using the statistical program SPSS® version 22 for
Windows (IBM corp.) The level of statistical significance was set at p < ÌĦÌĪĦĚÖŲŤŬŮŤrative
fibrinogen data were tested for normality using the Shapiro-Wilk’s test [16][17]. Both this test
and a visual inspection of the histogram, normal Q-Q plot and box plot showed that the
preoperative fibrinogen levels were approximately normally distributed across the study
population with a skewness of 0.961 (SE= 0.501) and a kurtosis of 1.366 (SE= 0.972)
[18][19][20].
Consequently, the univariate association of the preoperative fibrinogen levels and the primary
outcome (30-day mortality, survival at follow-up, re-intervention, endoleak and MACE) was
assessed by Independent Samples t-test. The preoperative fibrinogen levels were presented as
mean ± standard deviation (SD). The association of preoperative fibrinogen levels and the
survival at follow-up was investigated by Cox regression survival analysis.
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Histogram 1: the histogram of the preoperative fibrinogen levels’ distribution has the approximate shape of a normal
curve when visually inspected.
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Normal Q-Q plot 1:  the dots are approximately distributed along the line
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Box plot 1: the box plot is approximately symmetrical
RESULTS
Overall, twenty-one patients, 20 men and 1 woman with a median age of 71 years (range, 55-
87 years), underwent EVAR of a RAAA during the study period. Table I summarizes the
preoperative details of the patients included, patient characteristics, pre-existing
comorbidities and presenting features. The median duration of symptoms was 14 hours
(range, 4-72 hours). Approximately half the patients (48%) presented with hemodynamic
instability (i.e. a reduced level of consciousness and/or a systolic blood pressure (SBP) <80
mm Hg). A total of 5 patients presented with hypotension, defined as SBP < 90 mm Hg, and
the median lowest recorded SBP was 85mm Hg (30 mmHg-120 mmHg). The initial
hemoglobin was a median 11, 5 g/dL (range, 8, 05-13, 7 g/dL). Nineteen patients underwent
operation with local anesthetic infiltration in the groins, whereas two patients underwent the
procedure with general anesthesia.
De novo RAAAs were treated with fourteen bifurcated stent grafts and one aorto-uni-iliac
endograft with femoro-femoral crossover bypass. One spontaneous rupture of the abdominal
aorta was treated with tube endograft combined with the chimney-periscope technique. Those
cases with previous EVAR were treated either with an aortic (n=2) or an iliac extension
(n=3).
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A total of 3 patients died during the first 30 postoperative days (Table II). One died intra-
operatively due to exsanguination leading to cardiac arrest, while two died within 24 hours
after completion of the EVAR in the intensive care unit due to multiple organ failure
triggered by severe hypovolemia. Both of them developed intractable intraoperative
hypovolemic shock from which they never recovered, despite aggressive resuscitation and
after having received transfusion of a large amount of blood, blood products, and inotropes.
During a median follow-up of 10 months (range, 0-58 months) two further patients died. The
first patient died from pancreatic cancer and the second from cardio-respiratory failure.
During the postoperative follow-up, aortic related re-interventions were necessary in 4 (19%)
patients. The first encountered a type 1b endoleak within 3 months of the operation but
refused initially treatment. He eventually underwent implantation of an iliac limb extension.
Two patients developed a type 1a endoleak and subsequently underwent placement of an
aortic cuff extension. Finally, a fourth patient was readmitted with symptoms of left leg
ischemia due to endograft limb occlusion. A femoro-femoral crossover bypass was performed
but the patient eventually required an above-knee amputation.
There were also 5 cases of endoleaks in this group of patients (1 type Ib, 3 type Ia and 1 type
II). Finally, a total of 7 patients (33%) suffered a MACE during the existing follow-up.
Details are presented in Table III.
On average, preoperative fibrinogen levels were higher in the survivors (mean ± SD;
456.36±183.72 mg/dl vs. 192.57±52.26 mg/dl) than in the patients who died within 30-days.
This difference is statistically significant (p= 0.026). (Figure 1)
Beyond the 30-day follow-up, the preoperative fibrinogen levels were not significantly
different between survivors (mean ± SD; 446.84 ± 192.66 mg/dl) and patients who died
(mean ± SD; 328.54 ± 192.41 mg/dl, p= 0.245). (Figure 2)
Similarly, the preoperative fibrinogen levels were not significantly different in 1) patients that
required an aortic related re-intervention (vs not requiring re-intervention) (mean ± SD;
521.85 ± 311.43 vs. 394.40± 160.98 mg/dl, p= 0.249). (Figure 3) 2) in patients with an
endoleak (vs. no endoleak) (mean ±SD; 298.80 ± 167.00 vs 456.13 ± 191.90 mg/dl, p= 0.117)
(Figure 4), or 3) in patients suffering a MACE (vs not) (mean ± SD; 412.16 ± 270.20 vs
421.90 ± 156.80 mg/dl, p-value= 0.917) (Figure 5).
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 13:03:11 EET - 137.108.70.7
CHRISTINA PAPADIMITRIOU
ÍÍ
Table I Preoperative details
VARIABLE                                                DATA: No. (%) or median (range)
Age (year), median (range) 71 (55-87)
Sex (male/female) 22/1
Comorbidities
Coronary Artery Disease 13 (62%)
Hypertension 13 (62%)




Chronic renal impairment 1 (5%)
Previous abdominal operation 9 (43%)
Previous EVAR/De novo rupture 5 (24%)/16 (76%)
Presentation
Symptom duration (hours) median (range) 14 h (4-72 h)
Pain (abdominal/back) 21(100%)
Loss of consciousness 5 (24%)
Hemodynamically unstable 10 (48%)
Systolic Blood pressure (SBP) on admission 105 (30-170)
Hypotension on admission (<90mmHg) 5 (24%)
Lowest SBP 85(30-120)
Hb on admission g/dL, median (range) 11,5 (8,05-13,7)
Table II Primary Outcome
VARIABLE n (%) p-value
30-day mortality 3(14%) 0.026
Re-intervention (aortic related) 4(19%) 0.249
Endoleak 5(24%) 0.117
MACE 7(33%) 0.917
Survival at existing follow up 5(24%) 0.245
Table III Details about MACE
Patients MACE
1 Myocardial infraction
2 Left endograft limb occlusion, -lower limb ischemia, femoro-femoral
crossover bypass, -wound infection, above-knee amputation
3 Death in the ICU within 24 hours, multiple organ failure
4 Cardio respiratory failure, death 4 months later
5 Death in the ICU within 24 hours, multiple organ failure
6 Died intra-operatively, exsanguination leading to cardiac arrest
7 SFA occlusion causing claudication
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Finally, we examined the estimates of % survival in our series for a unit increase in the
preoperative fibrinogen level. A total of five patients died at follow-up  and  the value of
Exp(B) for fibrinogen level means that the death hazard is reduced by 100%-(100%*0.996)=
0.4% for each unit of increase in the preoperative fibrinogen level. As a result, fibrinogen is
supposed to be a protective factor for patients undergoing EVAR for RAAA giving better
chances of survival. However, this observed difference is not statistically significant (p-value;
p=0.218, 95% CI for Exp (B); (0,990-1,002)) in our small series. The cumulative survival
probability is presented graphically in Figure 6.
Figure 1: Box plot of the preoperative fibrinogen levels distribution across survivors and fatal cases in 30-day follow-
up
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Figure 2: Box plot of the preoperative fibrinogen levels distribution across survivors and fatal cases during existing
follow-up.
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Figure 3: Box plot of the preoperative fibrinogen levels distribution across patients requiring re-intervention and
patients with no need for re-intervention.
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Figure 4: Box plot of the preoperative fibrinogen levels distribution across patients with an endoleak and patients
without endoleak
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Figure 5: Box plot of the preoperative fibrinogen levels distribution across patients who suffered MACE and those
who did not
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Figure 6: Cox regression for survival analysis.  The basic survival curve is a visual display of the model predicted
time to death for the "average" patient. The horizontal axis shows the time to event in months. The vertical axis
shows the probability of survival
DISCUSSION
Despite the advances made in the surgical and the anesthetic techniques, RAAA remains one
of the most feared and difficult vascular emergencies with perioperative mortality figures
ranging in the 50 % range [21][22]. Major hemorrhage and hypotension after RAAA are
associated with worse outcome. In a study by Davies et al.[23] the major cause of immediate
intra-operative death in patients with a RAAA was related to hemorrhage. In RAAA-related
hemorrhage, survival is dependent upon immediate surgery and the application of an aortic
cross-clamp above the rupture site. Even if patients survive the hemorrhage, post-operative
mortality is still high due multiple organ failure, myocardial infarction, and
thromboembolism. A possible contributing mechanism for these complications is an
imbalance between the activation of the coagulation system and the fibrinolytic system.
Hemodynamic presentation can differ remarkably depending on the preoperative bleeding
which is related to the site and containment of the aortic rupture. If the outcome is to be
improved immediate efforts must be made to minimize perioperative blood loss. The
coagulation system is activated in patients with RAAA and shock, and the development of
coagulopathy predicts poor outcome [24].
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In RAAA patients, shock on admission is a well-known prognostic risk factor for mortality.
Apart from bleeding, a significant proportion of the deaths and complications in RAAA
patients are related to thrombosis. Activation of the coagulations system is regarded as an
important part of the thrombosis development.
The management of the patient with hemorrhage due to RAAA included rapid administration
of red blood cells, along with sufficient fresh frozen plasma and platelets to treat or prevent
coagulopathy. Furthermore,  Adam et al. [25] concluded that the procoagulant state in patients
with RAAA may contribute to microvascular and macrovascular thrombosis that, in turn, lead
to the common causes of perioperative morbidity and mortality, namely myocardial
infarction, multiple organ failure and thromboembolism.
The normal hemostatic system limits blood loss by a precisely regulated interaction between
components of the vessel wall, circulating blood platelets and coagulation factors. Thrombin
induces local hemostasis by activating platelets and by converting fibrinogen to fibrin. The
platelet aggregate with polymerized fibrin form a thrombus at the site of vascular injury.
Excessive thrombus formation is prevented by fibrinolysis. tPA and PAI have a central role
in the hemostatic balance. However, when these activities are not properly regulated the
organism is subjected to either excessive bleeding or thrombosis.
The hemostatic response during elective operation for AAA and in patients with multiple
trauma is well documented [26][27]. However, little is known about the hemostatic changes
during hemorrhage and shock in the patient with a RAAA. The use of the anti-fibrinolytic
drug, aprotinin, in cardiac surgery has reduced blood transfusion requirements [28]. It was
thought that a similar effect might occur in surgery for a RAAA. However, a clinical trial by
Robinson et al. [29] failed to demonstrate any benefit of the use of high-dose aprotinin during
the repair of a RAAA.
With regard to EVAR for RAAA, limited data exist examining correlations between
preoperative coagulopathy and outcome. Preoperative detection of coagulation abnormalities
may play a vital role to early correct deficiencies in the emergency surgical situation.
Fibrinogen, acts as one of the key-factors in the coagulation cascade, and has previously been
suggested as a biomarker for increased perioperative bleeding in other areas such as cardiac,
orthopedic, obstetric, and trauma surgery [30][31][32][33].
The present study attempted to investigate the impact of fibrinogen levels in the outcome of
RAAA patients undergoing EVAR. Statistical analysis revealed a significant association
between preoperative fibrinogen levels and 30-day mortality. It seems that the higher the
levels of fibrinogen are on presentation, the better chances of early survival the patients have.
However, no association was found between fibrinogen level and the possibility of the patient
presenting back to the hospital for an aortic related re-intervention or the possibility of
encountering an endoleak or a MACE. Equally, the findings showed no statistically
significant association between fibrinogen level and survival during the existing follow up.
The present study has certain limitations. First, the study suffers from small numbers, and as
such, may lead to a type II error. Second, this being a retrospective study, important variables
may not have been captured. Another limitation is lack of complete clinical information for
patients who were transferred from one hospital to another where treatment was received.
There could be unknown variables that affect patient outcome. Nevertheless, this is an
important pilot study and the results should be taken into account for future and larger
studies.
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In conclusion, higher fibrinogen levels on admission, which may indicate a preoperative
hypercoagulable profile, may be associated with better chances of early survival in RAAA
patients undergoing EVAR. Whether the outcome of these patients can be improved by
technically increasing fibrinogen levels through proactive administration of plasma or other
blood products, as soon the diagnosis of RAAA is made, remains to be seen.
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